Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 16, 2020 - Issue 4
Submit an article Journal homepage
2,524
Views
3
CrossRef citations to date
0
Altmetric
Editorial

The Fit fOR The Aged (FORTA) project and its clinical implications

Farhad PazanClinical Pharmacology Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, GermanyView further author information
&
Martin WehlingClinical Pharmacology Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, GermanyCorrespondence[email protected]
View further author information
Pages 275-277 | Received 10 Feb 2020, Accepted 10 Mar 2020, Published online: 21 Mar 2020

References

  • United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Ageing 2019: Highlights (ST/ESA/SER.A/430). Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=14&ved=2ahUKEwjOp4-1lKbnAhU1CWMBHUyuC7YQFjANegQIAhAB&url=https%3A%2F%2Fwww.un.org%2Fen%2Fdevelopment%2Fdesa%2Fpopulation%2Fpublications%2Fpdf%2Fageing%2FWorldPopulationAgeing2019-Highlights.pdf&usg=AOvVaw0C2HroVeVv_ijqlZBxbVhS
  • Wehling M. Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged FORTA. Dtsch Med Wochenschr. 2008 Oct;133:2289–2291. .
  • Pazan F, Kather J, Wehling M. A systematic review and novel classification of listing tools to improve medication in older people. Eur J Clin Pharmacol. 2019 May;75:619–625. .
  • By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019 Apr;67:674–694.
  • O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015 Mar;44:213–218.
  • Kuhn-Thiel AM, Weiss C, Wehling M. Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging. 2014 Feb;31:131–140. .
  • Pazan F, Weiss C, Wehling M. The EURO-FORTA (Fit fOR The Aged) List: international consensus validation of a clinical tool for improved drug treatment in older people. Drugs Aging. 2018 Jan;35:61–71. .
  • Pazan F, Gercke Y, Weiss C, et al. The U.S.-FORTA (Fit fOR The Aged) list: consensus validation of a clinical tool to improve drug therapy in older adults. J Am Med Dir Assoc. 2020 Mar;21:439. e9-439.e13 .
  • Wehling M, Collins R, Gil VM, et al. Appropriateness of oral anticoagulants for the long-term treatment of atrial fibrillation in older people: results of an evidence-based review and international consensus validation process (OAC-FORTA 2016). Drugs Aging. 2017 Jul;34:499–507.
  • Oelke M, Becher K, Castro-Diaz D, et al. Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014). Age Ageing. 2015 Sep;44:745–755.
  • Wehling M, Burkhardt H, Kuhn-Thiel A, et al. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing. 2016 Mar;45:262–267. .
  • Wehling M. How to Use the FORTA (“Fit fOR The Aged”) list to improve pharmacotherapy in the elderly. Drug Res (Stuttg). 2016 Feb;66:57–62.
  • Pazan F, Burkhardt H, Frohnhofen H, et al. Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments. Eur J Clin Pharmacol. 2018 Mar;74:339–347.
  • Pazan F, Burkhardt H, Frohnhofen H, et al. Higher Fit-fOR-The-Aged (FORTA) scores comprising medication errors are associated with impaired cognitive and physical function tests in the VALFORTA Trial. Drugs Aging. 2019 Mar;36:269–277.
  • Rabenberg A, Schulte T, Hildebrandt H, et al. The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: application of an information technology tool for the epidemiological assessment of drug treatment in older people. Drugs Aging. 2019 Oct;36:969–978.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.